iBio, Inc. (IBIO)
USD 2.4
(-0.83%)
USD 2.4
(-0.83%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 225 Thousand | - | 2.38 Million | 2.37 Million | 1.63 Million | 2.01 Million |
| Cost of Revenue | 1.25 Million | 1.1 Million | 216 Thousand | 1.46 Million | 703 Thousand | - |
| Gross Profit | -1.02 Million | -1.1 Million | 2.16 Million | 909 Thousand | 935 Thousand | 2.01 Million |
| Operating Expenses | 16.85 Million | 29.34 Million | 51.85 Million | 32.02 Million | 15.64 Million | 17.8 Million |
| Selling, General and Administrative Expenses | 11.67 Million | 19.01 Million | 34.12 Million | 22.03 Million | 12.42 Million | 12.33 Million |
| Research and Development Expenses | 5.18 Million | 10.32 Million | 17.72 Million | 9.98 Million | 3.21 Million | 5.47 Million |
| Other Expenses | - | - | 13 Thousand | 12 Thousand | 10 Thousand | 16 Thousand |
| Cost and Expenses | 16.85 Million | 29.34 Million | 52.07 Million | 33.48 Million | 15.64 Million | 17.8 Million |
| Operating Income | -16.63 Million | -29.31 Million | -49.69 Million | -31.11 Million | -14 Million | -15.78 Million |
| Interest Expense | 172 Thousand | - | 1.41 Million | 2.45 Million | 2.46 Million | 1.9 Million |
| Income Tax Expense | - | -1.63 Million | 701 Thousand | 46 Thousand | 2.47 Million | -4000.00 |
| Earnings before Tax | -15.44 Million | -29.31 Million | -50.3 Million | -23.21 Million | -16.44 Million | -17.59 Million |
| Net Income | -24.9 Million | -29.31 Million | -51 Million | -23.25 Million | -18.91 Million | -17.59 Million |
| Earnings Per Share Basic | -6.50 | -47.87 | -116.97 | -59.45 | -80.53 | -70.50 |
| Earnings Per Share Diluted | -6.50 | -47.87 | -116.97 | -59.45 | -80.53 | -70.50 |
| Weighted Average Shares Outstanding | 3.83 Million | 612.25 Thousand | 436.05 Thousand | 391.25 Thousand | 234.89 Thousand | 249.53 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.83 Million | 612.25 Thousand | 436.05 Thousand | 391.25 Thousand | 234.89 Thousand | 249.53 Thousand |
| Gross Margin | -4.56 | - | 0.91 | 0.38 | 0.57 | 1.00 |
| EBIT Margin | -62.32 | - | -19.18 | -13.06 | -7.17 | -6.91 |
| Profit Margin | -110.70 | - | -21.40 | -9.81 | -11.55 | -8.72 |
| EBITDA | -14.02 Million | -28.12 Million | -25.72 Million | -18.34 Million | -11.73 Million | -13.94 Million |
| Earnings Before Tax Margin | -73.93 | - | -20.85 | -13.12 | -8.55 | -7.82 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 225 Thousand | 175 Thousand | - | - | 50 Thousand | - |
| Cost of Revenue | - | -744 Thousand | 332 Thousand | 387 Thousand | 250 Thousand | 1.1 Million |
| Gross Profit | 225 Thousand | 919 Thousand | -332 Thousand | -387 Thousand | -200 Thousand | -1.1 Million |
| Operating Expenses | 16.85 Million | 3.58 Million | 3.29 Million | 4.49 Million | 5.15 Million | 29.34 Million |
| Selling, General and Administrative Expenses | - | 2.44 Million | 2.39 Million | 2.96 Million | 3.54 Million | - |
| Research and Development Expenses | - | 1.14 Million | 904 Thousand | 1.53 Million | 1.6 Million | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 16.85 Million | 3.58 Million | 3.62 Million | 4.49 Million | 5.15 Million | 29.34 Million |
| Operating Income | -15.44 Million | -3.4 Million | -3.62 Million | -4.49 Million | -5.1 Million | -29.31 Million |
| Interest Expense | -172 Thousand | 60 Thousand | 52 Thousand | 34 Thousand | 26 Thousand | -83 Thousand |
| Income Tax Expense | - | -1.29 Million | 537 Thousand | 34 Thousand | 727 Thousand | -1.63 Million |
| Earnings before Tax | -24.9 Million | -3.24 Million | -2.63 Million | -4.48 Million | -5.07 Million | -29.31 Million |
| Net Income | -24.9 Million | -7.77 Million | -3.17 Million | -8.21 Million | -5.74 Million | -29.31 Million |
| Earnings Per Share Basic | - | -2.03 | -0.85 | -4.42 | -4.79 | - |
| Earnings Per Share Diluted | - | -2.03 | -0.85 | -4.42 | -4.79 | - |
| Weighted Average Shares Outstanding | 3.83 Million | 3.83 Million | 3.71 Million | 1.85 Million | 1.19 Million | 612.25 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.83 Million | 3.83 Million | 3.71 Million | 1.85 Million | 1.19 Million | 612.25 Thousand |
| Gross Margin | 1.00 | 5.25 | - | - | -4.00 | - |
| EBIT Margin | - | -16.60 | - | - | -94.60 | - |
| Profit Margin | -110.70 | -44.45 | - | - | -114.92 | - |
| EBITDA | - | -2.9 Million | -3.29 Million | -4.13 Million | -4.73 Million | - |
| Earnings Before Tax Margin | -68.64 | -19.48 | - | - | -102.06 | - |
MONOF
9706
WOR
ECORF
688613
IMCO